中大學術數位典藏-NCU Institutional Repository:Item 987654321/102655
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 94459/94459 (100%)
造访人次 : 87654154      在线人数 : 238
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.lib.ncu.edu.tw/handle/987654321/102655


    题名: Vav3-Rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence
    作者: 王陸海;Lin, Kai-Ti;Gong, Jianli;Li, Chien-Feng;Jang, Te-Hsuan;Chen, Wen-Ling;Chen, Huei-Jane;Wang, Lu-Hai
    贡献者: 生醫理工學院生命科學系
    日期: 2012-06-15
    上传时间: 2026-04-23 11:14:21 (UTC+8)
    出版者: American Association for Cancer Research Inc.;American Association for Cancer Research (AACR)
    摘要: 摘要: AbstractProstate cancer remains the second leading cause of cancer death in men in the Western world. Yet current therapies do not significantly improve the long-term survival of patients with distant metastasis. In this study, we investigated the role of the guanine nucleotide exchange factor Vav3 in prostate cancer progression and metastasis and found that Vav3 expression correlated positively with prostate cancer cell migration and invasion. Stimulation of the receptor tyrosine kinase EphA2 by ephrinA1 resulted in recruitment and tyrosine phosphorylation of Vav3, leading to Rac1 activation as well as increased migration and invasion in vitro. Reduction of Vav3 resulted in fewer para-aortic lymph nodes and bone metastasis in vivo. Clinically, expression of Vav3 and EphA2 was elevated in late-stage and metastatic prostate cancers. Among patients with stage IIB or earlier prostate cancer, higher Vav3 expression correlated with lower cumulative biochemical failure-free survival, suggesting that Vav3 may represent a prognostic marker for posttreatment recurrence of prostate cancer. Together, our findings provide evidence that the Vav3-mediated signaling pathway may serve as a therapeutic target for prostate cancer metastasis. Cancer Res; 72(12); 3000–9. ©2012 AACR.
    出版者: American Association for Cancer Research (AACR)
    出版日期: 2012-06-14
    出處: Cancer Research, 2012-06, Vol.72 (12), p.3000-3009
    識別號: ISSN: 0008-5472
    識別號: DOI: 10.1158/0008-5472.can-11-2502
    显示于类别:[生命科學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML39检视/开启


    在NCUIR中所有的数据项都受到原著作权保护.

    社群 sharing

    ::: Copyright National Central University. | 國立中央大學圖書館版權所有 | 收藏本站 | 設為首頁 | 最佳瀏覽畫面: 1024*768 | 建站日期:8-24-2009 :::
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 隱私權政策聲明